Efficacy validation of equinovarus suppression ankle foot orthosis for stroke hemiparesis

Efficacy validation of equinovarus suppression ankle foot orthosis for stroke hemiparesis - Efficacy validation of equinovarus suppression ankle foot orthosis for stroke hemiparesis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022782

Enrollment

Registered

2016-06-19

Start date

2016-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Equinovarus of stroke hemiplegia

Interventions

The patient carries out the four tasks shown below in clinical trial once. The task is carried out all at random. Task 1 Without the application of the orthosis Carry out the 10m walking 5 times

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Able to walk in the Brunnstrom stage 3 or more 2. Having sufficient joint mobility (dorsiflexion 5[deg]~ plantar flexion 30[deg]) 3. It does not have the anesthesia 4. Mini Mental State Examination: 23 points or more 5. Frontal Assessment Battery: 12 points or more

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
To measure the transition of the position of the center of gravity at the time of walking by applying the orthosis to the patient. This clinical trial will be carried out for about 6 to 10 times in one month. The number of times of the clinical trials by the judgment of the practitioner is increased.	—

Countries

Japan

Contacts

Public ContactHiroyasu Iwata

Waseda University Faculty of Science and Engineering

jubi@waseda.jp03-3203-4531

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026